Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Modeling α-Synuclein Propagation with Preformed Fibril Injections
Hyun Kyung Chung, Hoang-Anh Ho, Dayana Pérez-Acuña, et al.
Journal of Movement Disorders (2019) Vol. 12, Iss. 3, pp. 139-151
Open Access | Times Cited: 84

Showing 1-25 of 84 citing articles:

Modeling Parkinson’s Disease With the Alpha-Synuclein Protein
Mónica Gómez-Benito, Noelia Granado, Patricia García‐Sanz, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 317
Exploring the Etiological Links behind Neurodegenerative Diseases: Inflammatory Cytokines and Bioactive Kynurenines
Masaru Tanaka, József Toldi, László Vécsei
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 7, pp. 2431-2431
Open Access | Times Cited: 215
Impaired dopamine release in Parkinson’s disease
Kaitlyn M. L. Cramb, Dayne Beccano-Kelly, Stephanie J. Cragg, et al.
Brain (2023) Vol. 146, Iss. 8, pp. 3117-3132
Open Access | Times Cited: 89
Animal models of Parkinson’s disease: bridging the gap between disease hallmarks and research questions
Axelle Dovonou, Cyril Bolduc, Victoria Soto Linan, et al.
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 54
Neuropathogenesis-on-chips for neurodegenerative diseases
Sarnai Amartumur, Huong Mai Nguyen, Thuy Huynh, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 32
Dysbiosis of the gut microbiota and its effect on α-synuclein and prion protein misfolding: consequences for neurodegeneration
Nasir Uddin Mahbub, Md Minarul Islam, Seong‐Tshool Hong, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 17
Trans-synaptic spreading of alpha-synuclein pathology through sensory afferents leads to sensory nerve degeneration and neuropathic pain
Nelson Ferreira, Nádia Pereira Gonçalves, Asad Jan, et al.
Acta Neuropathologica Communications (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 59
CSF-derived extracellular vesicles from patients with Parkinson’s disease induce symptoms and pathology
Shay Herman, Ruth Djaldetti, Brit Mollenhauer, et al.
Brain (2022) Vol. 146, Iss. 1, pp. 209-224
Open Access | Times Cited: 44
Duodenal alpha‐Synuclein Pathology and Enteric Gliosis in Advanced Parkinson's Disease
Aron Emmi, Michele Sandre, Francesco Paolo Russo, et al.
Movement Disorders (2023) Vol. 38, Iss. 5, pp. 885-894
Open Access | Times Cited: 29
Advanced human iPSC-based preclinical model for Parkinson’s disease with optogenetic alpha-synuclein aggregation
Min Seong Kim, Eun A., Sin Ho Kweon, et al.
Cell stem cell (2023) Vol. 30, Iss. 7, pp. 973-986.e11
Open Access | Times Cited: 25
Apathy in Parkinson’s Disease: Clinical Patterns and Neurobiological Basis
Matthieu Béreau, Vincent Van Waes, Mathieu Servant, et al.
Cells (2023) Vol. 12, Iss. 12, pp. 1599-1599
Open Access | Times Cited: 24
Glial senescence enhances α-synuclein pathology owing to its insufficient clearance caused by autophagy dysfunction
Bin Hong, Yosuke Ohtake, Takahide Itokazu, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 13
Animal Models of Metabolic Disorders in the Study of Neurodegenerative Diseases: An Overview
Andreza Fabro de, Rachel Krolow, Hémelin Resende Farias, et al.
Frontiers in Neuroscience (2021) Vol. 14
Open Access | Times Cited: 54
α-Synuclein in Parkinson's disease and advances in detection
Rong Chen, Xuan Gu, Xiaoying Wang
Clinica Chimica Acta (2022) Vol. 529, pp. 76-86
Closed Access | Times Cited: 33
Phosphorylation of endogenous α-synuclein induced by extracellular seeds initiates at the pre-synaptic region and spreads to the cell body
Shiori Awa, Genjiro Suzuki, Masami Masuda‐Suzukake, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 30
Endogenous Levels of Alpha-Synuclein Modulate Seeding and Aggregation in Cultured Cells
Eftychia Vasili, Antonio Dominguez‐Meijide, Manuel Flores‐León, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 2, pp. 1273-1284
Open Access | Times Cited: 30
Non-invasive Monitoring of α-Synuclein in Saliva for Parkinson’s Disease Using Organic Electrolyte-Gated FET Aptasensor
Roslyn S. Massey, Erin M. McConnell, Dennis Chan, et al.
ACS Sensors (2023) Vol. 8, Iss. 8, pp. 3116-3126
Closed Access | Times Cited: 21
Unconventional secretion of α-synuclein mediated by palmitoylated DNAJC5 oligomers
Shenjie Wu, Nancy C. Hernandez Villegas, Daniel W. Sirkis, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 20
The Role of α-Synuclein in the Regulation of Serotonin System: Physiological and Pathological Features
Lluís Miquel-Rio, Unai Sarriés-Serrano, Rubén Pavia-Collado, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 541-541
Open Access | Times Cited: 20
Peripheral Inflammation Regulates CNS Immune Surveillance Through the Recruitment of Inflammatory Monocytes Upon Systemic α-Synuclein Administration
Javier María Peralta Ramos, Pablo Iribarren, Luc Bousset, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 49
Pathogenic Mutations Differentially Regulate Cell-to-Cell Transmission of α-Synuclein
Yuan Guan, Xiaofang Zhao, Fengwei Liu, et al.
Frontiers in Cellular Neuroscience (2020) Vol. 14
Open Access | Times Cited: 41
Dopamine, Alpha-Synuclein, and Mitochondrial Dysfunctions in Parkinsonian Eyes
Alessia Indrieri, Rocco Pizzarelli, Brunella Franco, et al.
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 41
A Surface Imprinted Polymer EIS Sensor for Detecting Alpha-Synuclein, a Parkinson’s Disease Biomarker
Roslyn S. Massey, Rishabh Ramesh Appadurai, Ravi Prakash
Micromachines (2024) Vol. 15, Iss. 2, pp. 273-273
Open Access | Times Cited: 5
Classic and evolving animal models in Parkinson's disease
Tanvi Pingale, Girdhari Lal Gupta
Pharmacology Biochemistry and Behavior (2020) Vol. 199, pp. 173060-173060
Closed Access | Times Cited: 35
Stress-inducible phosphoprotein 1 (HOP/STI1/STIP1) regulates the accumulation and toxicity of α-synuclein in vivo
Rachel E. Lackie, Aline Silva de Miranda, Mei Peng Lim, et al.
Acta Neuropathologica (2022) Vol. 144, Iss. 5, pp. 881-910
Open Access | Times Cited: 20
Page 1 - Next Page

Scroll to top